| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.07 |